MyMD Pharmaceuticals, Inc.
NASDAQ:MYMD
1.81 (USD) • At close July 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 1.577 | 1.666 | 3.93 | 2.961 | 2.115 | 4.427 | 3.578 | 1.522 | 1.785 | 3.053 | 1.844 | 6.078 | 5.519 | 1.021 | 4.61 |
Cost of Revenue
| 0 | 0 | 0 | 0.029 | 0.074 | 1.538 | 1.42 | 1.083 | 0.951 | 1.175 | 1.914 | 0.976 | 0.895 | 1.288 | 1.101 | 1.371 | 2.014 | 2.464 | 2.94 |
Gross Profit
| 0 | 0 | 0 | -0.029 | 1.503 | 0.127 | 2.51 | 1.878 | 1.164 | 3.252 | 1.664 | 0.546 | 0.891 | 1.766 | 0.743 | 4.707 | 3.505 | -1.443 | 1.67 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0.953 | 0.076 | 0.639 | 0.634 | 0.55 | 0.735 | 0.465 | 0.359 | 0.499 | 0.578 | 0.403 | 0.774 | 0.635 | -1.413 | 0.362 |
Reseach & Development Expenses
| 7.868 | 9.067 | 6.745 | 2.467 | 3.628 | 1.063 | 1.26 | 1.189 | 1.407 | 0.916 | 1.007 | 0.717 | 0.698 | 0.675 | 0.662 | 0.432 | 0.126 | 0.787 | 0.79 |
General & Administrative Expenses
| 5.443 | 6.215 | 21.456 | 5.811 | 5.765 | 5.666 | 4.082 | 3.009 | 4.03 | 3.979 | 1.525 | 1.49 | 3.278 | 1.886 | 4.312 | 0.152 | 0.283 | 0 | 0 |
Selling & Marketing Expenses
| 8.487 | 0 | 0 | 0.023 | 0.238 | 1.782 | 2.049 | 2.137 | 2.543 | 1.302 | 0.685 | 0.639 | 0.708 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 8.492 | 6.215 | 21.456 | 5.811 | 3.323 | 7.448 | 6.131 | 5.146 | 6.573 | 5.281 | 2.209 | 2.128 | 3.986 | 1.886 | 4.312 | 0.152 | 0.283 | 0 | 0 |
Other Expenses
| -0.763 | 0 | 0 | 0.018 | 0.04 | 0.171 | 0.171 | 0.171 | 0.237 | 0.259 | 0.259 | 0.32 | 0.059 | 0.337 | 0.435 | 2.106 | 4.837 | 6.599 | 3.086 |
Operating Expenses
| 17.123 | 15.283 | 28.201 | 8.296 | 3.323 | 8.683 | 7.562 | 6.506 | 8.216 | 6.456 | 3.475 | 3.166 | 4.743 | 2.898 | 5.409 | 2.689 | 5.246 | 7.386 | 3.876 |
Operating Income
| -17.123 | -15.283 | -28.81 | -9.488 | -3.397 | -8.555 | -5.053 | -4.628 | -7.052 | -3.204 | -1.811 | -2.619 | -3.853 | -1.133 | -4.666 | 2.018 | -1.741 | -8.829 | -2.205 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | -2.154 | -5.137 | -1.286 | -1.563 | -3.334 | -0.724 | -0.506 | -1.721 | -2.158 | -0.371 | -2.53 | 0.332 | -0.315 | -8.648 | -0.478 |
Total Other Income Expenses Net
| 13.123 | 0.085 | -1.079 | 0 | 0.016 | -2.294 | -0.753 | 1.325 | -2.529 | 0.077 | 0.284 | 0.007 | -0.029 | -0.071 | 0.038 | -3.253 | -0.624 | -1.255 | -2.302 |
Income Before Tax
| -4 | -15.197 | -29.889 | -9.488 | -3.381 | -10.849 | -5.805 | -3.304 | -9.581 | -3.127 | -1.527 | -2.612 | -3.882 | -1.203 | -4.628 | -1.235 | -2.365 | -10.084 | -4.507 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -2.144 | -6.514 | -1.477 | -1.116 | -4.53 | -0.706 | -0.427 | -1.716 | -2.175 | -0.394 | -2.51 | -0.203 | -0.429 | -9.877 | -0.978 |
Income Tax Expense
| 4.218 | -0.085 | -0.009 | 1.192 | -0.084 | -2.294 | -0.753 | 1.325 | -0.269 | 0.016 | 0.284 | -0.163 | -0.298 | -0.283 | 0.038 | -0.7 | -0.64 | -0.489 | 0 |
Net Income
| -4 | -15.112 | -29.88 | -10.68 | -3.888 | -10.849 | -5.805 | -3.304 | -9.312 | -3.127 | -1.527 | -2.449 | -3.584 | -0.92 | -4.628 | -0.535 | -1.725 | -9.595 | -4.507 |
Net Income Ratio
| 0 | 0 | 0 | 0 | -2.466 | -6.514 | -1.477 | -1.116 | -4.403 | -0.706 | -0.427 | -1.609 | -2.008 | -0.301 | -2.51 | -0.088 | -0.312 | -9.398 | -0.978 |
EPS
| -2.59 | -11.68 | -25.6 | -90.86 | -380.79 | -23.73 | -117.39 | -116.81 | -347.78 | -126.52 | -183.59 | -411.4 | -657.79 | -240.93 | -1,221.43 | -257.54 | -829.94 | -5,063.14 | -2,697.3 |
EPS Diluted
| -2.59 | -11.68 | -25.6 | -90.86 | -380.79 | -23.73 | -117.39 | -116.81 | -347.78 | -126.52 | -183.59 | -411.4 | -657.79 | -240.93 | -1,221.43 | -257.54 | -829.94 | -5,063.14 | -2,697.3 |
EBITDA
| -17.123 | -15.199 | -28.192 | -8.278 | -3.323 | -10.615 | -5.555 | -3.017 | -9.281 | -2.778 | -1.172 | -2.075 | -3.357 | -0.719 | -3.708 | 0.593 | -1.741 | -8.829 | -3.857 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | -2.107 | -6.373 | -1.414 | -1.019 | -4.388 | -0.627 | -0.328 | -1.363 | -1.881 | -0.236 | -2.01 | 0.097 | -0.315 | -8.648 | -0.837 |